Here is how Gerald raises the pps above .10 cents instantly: he has a CC and gives more revenue guidance on Lympro based on recent discussions they've had with pharmas doing AD trials. If they are getting intense interest and he was able to indicate that, the pps would shoot up fast.

I don't know exactly where AMBS is in the "soft selling" process of Lymrpo to AD pharmas. JP mentioned yesterday that it would be nice to see a "work order" for LymPro on an AD trial starting in December.

I don't think it would take very much of this kind of evidence to instill confidence in the market about LymPro and AMBS.